Literature DB >> 26803842

Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.

Luis A Cea1,2, Carlos Puebla3,4, Bruno A Cisterna3,4, Rosalba Escamilla3,4, Aníbal A Vargas3, Marina Frank5, Paloma Martínez-Montero6, Carmen Prior6, Jesús Molano6, Isabel Esteban-Rodríguez7, Ignacio Pascual8, Pía Gallano9, Gustavo Lorenzo10, Héctor Pian11, Luis C Barrio12, Klaus Willecke5, Juan C Sáez13,14.   

Abstract

Skeletal muscles of patients with Duchenne muscular dystrophy (DMD) show numerous alterations including inflammation, apoptosis, and necrosis of myofibers. However, the molecular mechanism that explains these changes remains largely unknown. Here, the involvement of hemichannels formed by connexins (Cx HCs) was evaluated in skeletal muscle of mdx mouse model of DMD. Fast myofibers of mdx mice were found to express three connexins (39, 43 and 45) and high sarcolemma permeability, which was absent in myofibers of mdx Cx43(fl/fl)Cx45(fl/fl):Myo-Cre mice (deficient in skeletal muscle Cx43/Cx45 expression). These myofibers did not show elevated basal intracellular free Ca(2+) levels, immunoreactivity to phosphorylated p65 (active NF-κB), eNOS and annexin V/active Caspase 3 (marker of apoptosis) but presented dystrophin immunoreactivity. Moreover, muscles of mdx Cx43(fl/fl)Cx45(fl/fl):Myo-Cre mice exhibited partial decrease of necrotic features (big cells and high creatine kinase levels). Accordingly, these muscles showed similar macrophage infiltration as control mdx muscles. Nonetheless, the hanging test performance of mdx Cx43(fl/fl)Cx45(fl/fl):Myo-Cre mice was significantly better than that of control mdx Cx43(fl/fl)Cx45(fl/fl) mice. All three Cxs found in skeletal muscles of mdx mice were also detected in fast myofibers of biopsy specimens from patients with muscular dystrophy. Thus, reduction of Cx expression and/or function of Cx HCs may be potential therapeutic approaches to abrogate myofiber apoptosis in DMD.

Entities:  

Keywords:  Cell death; Connexons; Evans blue uptake; NF-κB; P2X7 receptors; Pannexin1

Mesh:

Substances:

Year:  2016        PMID: 26803842     DOI: 10.1007/s00018-016-2132-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  59 in total

1.  Connexins are mechanosensitive.

Authors:  Li Bao; Frederick Sachs; Gerhard Dahl
Journal:  Am J Physiol Cell Physiol       Date:  2004-11       Impact factor: 4.249

Review 2.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

3.  Deletion of connexin45 in mouse retinal neurons disrupts the rod/cone signaling pathway between AII amacrine and ON cone bipolar cells and leads to impaired visual transmission.

Authors:  Stephan Maxeiner; Karin Dedek; Ulrike Janssen-Bienhold; Josef Ammermüller; Hendrik Brune; Taryn Kirsch; Mario Pieper; Joachim Degen; Olaf Krüger; Klaus Willecke; Reto Weiler
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

4.  Endothelium-specific replacement of the connexin43 coding region by a lacZ reporter gene.

Authors:  M Theis; C de Wit ; T M Schlaeger; D Eckardt; O Krüger; B Döring; W Risau; U Deutsch; U Pohl; K Willecke
Journal:  Genesis       Date:  2001-01       Impact factor: 2.487

5.  Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.

Authors:  B L Bia; P J Cassidy; M E Young; J A Rafael; B Leighton; K E Davies; G K Radda; K Clarke
Journal:  J Mol Cell Cardiol       Date:  1999-10       Impact factor: 5.000

6.  Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes.

Authors:  R P Kondo; S Y Wang; S A John; J N Weiss; J I Goldhaber
Journal:  J Mol Cell Cardiol       Date:  2000-10       Impact factor: 5.000

7.  The ATP required for potentiation of skeletal muscle contraction is released via pannexin hemichannels.

Authors:  Manuel A Riquelme; Luis A Cea; José L Vega; Mauricio P Boric; Hannah Monyer; Michael V L Bennett; Marina Frank; Klaus Willecke; Juan C Sáez
Journal:  Neuropharmacology       Date:  2013-04-11       Impact factor: 5.250

8.  Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors.

Authors:  Yuko Iwata; Yuki Katanosaka; Takashi Hisamitsu; Shigeo Wakabayashi
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 9.  What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?

Authors:  Alex Perálvarez-Marín; Pau Doñate-Macian; Rachelle Gaudet
Journal:  FEBS J       Date:  2013-05-28       Impact factor: 5.542

10.  Intracellular calcium and force in single mouse muscle fibres following repeated contractions with stretch.

Authors:  C D Balnave; D G Allen
Journal:  J Physiol       Date:  1995-10-01       Impact factor: 5.182

View more
  14 in total

Review 1.  Joint diseases: from connexins to gap junctions.

Authors:  Henry J Donahue; Roy W Qu; Damian C Genetos
Journal:  Nat Rev Rheumatol       Date:  2017-12-19       Impact factor: 20.543

2.  Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy.

Authors:  Eric Himelman; Mauricio A Lillo; Julie Nouet; J Patrick Gonzalez; Qingshi Zhao; Lai-Hua Xie; Hong Li; Tong Liu; Xander Ht Wehrens; Paul D Lampe; Glenn I Fishman; Natalia Shirokova; Jorge E Contreras; Diego Fraidenraich
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 3.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 4.  Connexins and Pannexins in Bone and Skeletal Muscle.

Authors:  Lilian I Plotkin; Hannah M Davis; Bruno A Cisterna; Juan C Sáez
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

5.  GsMTx4-D provides protection to the D2.mdx mouse.

Authors:  Christopher W Ward; Frederick Sachs; Ernest D Bush; Thomas M Suchyna
Journal:  Neuromuscul Disord       Date:  2018-07-21       Impact factor: 3.538

6.  On Biophysical Properties and Sensitivity to Gap Junction Blockers of Connexin 39 Hemichannels Expressed in HeLa Cells.

Authors:  Anibal A Vargas; Bruno A Cisterna; Fujiko Saavedra-Leiva; Carolina Urrutia; Luis A Cea; Alex H Vielma; Sebastian E Gutierrez-Maldonado; Alberto J M Martin; Claudia Pareja-Barrueto; Yerko Escalona; Oliver Schmachtenberg; Carlos F Lagos; Tomas Perez-Acle; Juan C Sáez
Journal:  Front Physiol       Date:  2017-02-09       Impact factor: 4.566

7.  Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophy.

Authors:  Silvia Parolo; Luca Marchetti; Mario Lauria; Karla Misselbeck; Marie-Pier Scott-Boyer; Laura Caberlotto; Corrado Priami
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

Review 8.  eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle Diseases.

Authors:  Chiara Panicucci; Lizzia Raffaghello; Santina Bruzzone; Serena Baratto; Elisa Principi; Carlo Minetti; Elisabetta Gazzerro; Claudio Bruno
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

9.  Long-term PGC1β overexpression leads to apoptosis, autophagy and muscle wasting.

Authors:  Danesh H Sopariwala; Vikas Yadav; Pierre-Marie Badin; Neah Likhite; Megha Sheth; Sabina Lorca; Isabelle K Vila; Eun Ran Kim; Qingchun Tong; Min Sup Song; George G Rodney; Vihang A Narkar
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

10.  Connexin-43 reduction prevents muscle defects in a mouse model of manifesting Duchenne muscular dystrophy female carriers.

Authors:  Julie Nouet; Eric Himelman; Kevin C Lahey; Qingshi Zhao; Diego Fraidenraich
Journal:  Sci Rep       Date:  2020-03-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.